Literature DB >> 26333654

New patients with Temple syndrome caused by 14q32 deletion: Genotype-phenotype correlations and risk of thyroid cancer.

Giulia Severi1, Laura Bernardini2, Silvana Briuglia3, Stefania Bigoni4, Barbara Buldrini4, Pamela Magini1, Maria L Dentici5, Duccio M Cordelli6, Teresa Arrigo3, Emilio Franzoni6, Sergio Fini4, Eleonora Italyankina4, Italia Loddo3, Antonio Novelli5, Claudio Graziano1.   

Abstract

Temple syndrome (TS) is caused by abnormal expression of genes at the imprinted locus 14q32. A subset of TS patients carry 14q32 deletions of paternal origin. We aimed to define possible genotype-phenotype correlations and to highlight the prevalence of thyroid dysfunction, which is a previously unreported feature of TS. We described four new patients who carry deletions of paternal origin at 14q32 detected by array-CGH and reviewed nine patients reported in the medical literature. We compared clinical features with respect to deletion size and position. Expression of DLK1 is altered in all the patients with TS, but intellectual disability (ID) is present only in patients with larger deletions extending proximally to the imprinted locus. This study led to the identification of an ID "critical region" containing four annotated genes including YY1 as the strongest candidate. Furthermore, we described three patients with thyroid dysfunction, which progressed to papillary carcinoma at a very young age in two of them. We conclude that DLK1 loss of function is likely to be responsible for the core features of TS, while haploinsufficiency of a gene outside the imprinted region causes ID. Thyroid cancer may be an unrecognized feature and monitoring for thyroid dysfunction should thus be considered in TS patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  14q32 deletion; DIO3; DLK1; Temple syndrome; YY1; thyroid cancer

Mesh:

Year:  2015        PMID: 26333654     DOI: 10.1002/ajmg.a.37346

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.

Authors:  Jasmin Beygo; Alma Küchler; Gabriele Gillessen-Kaesbach; Beate Albrecht; Jonas Eckle; Thomas Eggermann; Alexandra Gellhaus; Deniz Kanber; Ulrike Kordaß; Hermann-Josef Lüdecke; Sabine Purmann; Eva Rossier; Johannes van de Nes; Ilse M van der Werf; Maren Wenzel; Dagmar Wieczorek; Bernhard Horsthemke; Karin Buiting
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

2.  Maternally inherited 133kb deletion of 14q32 causing Kagami-Ogata syndrome.

Authors:  Hou-Sung Jung; Stephanie E Vallee; Mary Beth Dinulos; Gregory J Tsongalis; Joel A Lefferts
Journal:  J Hum Genet       Date:  2018-09-19       Impact factor: 3.172

3.  A New Case of a Rare Combination of Temple Syndrome and Mosaic Trisomy 14 and a Literature Review.

Authors:  Maria Yakoreva; Tiina Kahre; Sander Pajusalu; Piret Ilisson; Olga Žilina; Vallo Tillmann; Tiia Reimand; Katrin Õunap
Journal:  Mol Syndromol       Date:  2018-05-18

4.  YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction.

Authors:  Michele Gabriele; Anneke T Vulto-van Silfhout; Pierre-Luc Germain; Alessandro Vitriolo; Raman Kumar; Evelyn Douglas; Eric Haan; Kenjiro Kosaki; Toshiki Takenouchi; Anita Rauch; Katharina Steindl; Eirik Frengen; Doriana Misceo; Christeen Ramane J Pedurupillay; Petter Stromme; Jill A Rosenfeld; Yunru Shao; William J Craigen; Christian P Schaaf; David Rodriguez-Buritica; Laura Farach; Jennifer Friedman; Perla Thulin; Scott D McLean; Kimberly M Nugent; Jenny Morton; Jillian Nicholl; Joris Andrieux; Asbjørg Stray-Pedersen; Pascal Chambon; Sophie Patrier; Sally A Lynch; Susanne Kjaergaard; Pernille M Tørring; Charlotte Brasch-Andersen; Anne Ronan; Arie van Haeringen; Peter J Anderson; Zöe Powis; Han G Brunner; Rolph Pfundt; Janneke H M Schuurs-Hoeijmakers; Bregje W M van Bon; Stefan Lelieveld; Christian Gilissen; Willy M Nillesen; Lisenka E L M Vissers; Jozef Gecz; David A Koolen; Giuseppe Testa; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

5.  Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.

Authors:  Murilo Vieira Geraldo; Helder Imoto Nakaya; Edna Teruko Kimura
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  Growth Restriction and Genomic Imprinting-Overlapping Phenotypes Support the Concept of an Imprinting Network.

Authors:  Thomas Eggermann; Justin H Davies; Maithé Tauber; Erica van den Akker; Anita Hokken-Koelega; Gudmundur Johansson; Irène Netchine
Journal:  Genes (Basel)       Date:  2021-04-17       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.